Results-driven CEO/CFO. 25+ years' business/operational finance experience. Develop global financial strategy, raise capital, manage investments, create sustainable value, implement efficiencies and internal controls, M&A integration, problem solve and IR. M&A experience includes acquisitions and divestitures.
Armed with quantitative and analytical skills, I am well-equipped to address pressing challenges and capitalize on opportunities. Managed teams of 100+ in economically volatile environments, Accustomed to solving multiple issues creatively and under extreme pressure. I actively anticipate when to implement changes in direction, prioritizing and delegating tasks, and motivating others to achieve targeted objectives in a timely and efficient manner.
Key strengths include: FINANCE • Lead continuous evaluation of short/long-term strategic financial objectives • Optimize management of capital sources and their uses • M&A • Investor Relations (manage relationships with financial markets; lenders; investors; etc.) • Timely, accurate analysis of budgets, financial trends and forecasts • Audit, budget and financial forecasting • Strategically enhance financial performance and business opportunities • Seek and negotiate capital raising transactions • Ensure effective internal controls, compliance with GAAP and applicable regs governing financial and tax reporting MANAGEMENT/LEADERSHIP • Develop strategic plan • Hire, motivate and direct teams of men and women • Create new organizations and deploy work force BUSINESS DEVELOPMENT • Design strategies to achieve, sustain and recapture market leadership and growth • Expand geographic footprint/wholesale and retail franchise operations in appropriate global markets • Launch new product lines • Increase manufacturing capabilities • Improve brand name recognition COMMUNICATION • Liaise with media in connection with PR strategy
Experience
Company Name Cognate BioServices Total Duration 3 yrs 11 mos
Title Special Advisor, Strategy and Corporate Finance Dates Employed Mar 2018 – Present Employment Duration 10 mos Location Greater New York City Area I act as special advisor to the senior executive management team, drawing on deep expertise in strategy and corporate finance to drive value creation, growth and optimal allocation of resources.
Cogent is defined as clear, logical, and convincing,
Adnate is defined as 'joined by having grown together.'
Either would be curiously apposite.
Or maybe even Toucan Tango. Lol.
Also quite fitting, it has to be said!
"Following revised business plans, application for MHRA/ HTA license will be Q3 2019."
I suppose it should be mentioned that in last years report, the target for licencing was Q2 2018. So we are almost certainly looking at further mothballing.
I imagine that they want to see what finally happens with Brexit, which may lead to two sets of GMP guidelines, parallel licencing regimes, and set up rules regarding requirements for exporting CGT products into Europe.
Just as well we have the right man onboard in respect of the above in Prof Lowdell.
News 
Market Data 
Discover 
AI
